[go: up one dir, main page]

LV5624A3 - Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai - Google Patents

Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai

Info

Publication number
LV5624A3
LV5624A3 LV930507A LV930507A LV5624A3 LV 5624 A3 LV5624 A3 LV 5624A3 LV 930507 A LV930507 A LV 930507A LV 930507 A LV930507 A LV 930507A LV 5624 A3 LV5624 A3 LV 5624A3
Authority
LV
Latvia
Prior art keywords
deoxy
contribution
obtaining
fluorocytidine derivatives
fluorocytidine
Prior art date
Application number
LV930507A
Other languages
English (en)
Latvian (lv)
Inventor
Morio Fujiu
Hideo Ishitsuka
Masanori Miwa
Isao Umeda
Kazuteru Yokose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LV5624A3 publication Critical patent/LV5624A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LV930507A 1987-11-17 1993-06-08 Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai LV5624A3 (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87116926 1987-11-17
SU884356869A SU1736342A3 (ru) 1987-11-17 1988-11-16 Способ получени производных 5 @ -дезокси-5-фторцитидина

Publications (1)

Publication Number Publication Date
LV5624A3 true LV5624A3 (lv) 1994-05-10

Family

ID=8197450

Family Applications (1)

Application Number Title Priority Date Filing Date
LV930507A LV5624A3 (lv) 1987-11-17 1993-06-08 Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai

Country Status (35)

Country Link
US (1) US4966891A (fr)
EP (1) EP0316704B1 (fr)
JP (1) JPH0678350B2 (fr)
KR (1) KR970000241B1 (fr)
CN (1) CN1022688C (fr)
AR (1) AR247217A1 (fr)
AT (1) ATE124951T1 (fr)
AU (1) AU619220B2 (fr)
CA (1) CA1327358C (fr)
CS (1) CS274486B2 (fr)
DE (2) DE10199027I2 (fr)
DK (1) DK170893B1 (fr)
DZ (1) DZ1270A1 (fr)
ES (1) ES2074429T3 (fr)
FI (1) FI89804C (fr)
GR (1) GR3017686T3 (fr)
HK (1) HK1003114A1 (fr)
HU (1) HU199866B (fr)
IE (1) IE883430L (fr)
IL (1) IL88363A0 (fr)
IS (1) IS1895B (fr)
LT (1) LT2185B (fr)
LU (1) LU90769I2 (fr)
LV (1) LV5624A3 (fr)
MC (1) MC1992A1 (fr)
MX (1) MX173347B (fr)
NL (1) NL300045I2 (fr)
NO (2) NO171167C (fr)
NZ (1) NZ226923A (fr)
PH (1) PH25641A (fr)
PT (1) PT89009B (fr)
SU (1) SU1736342A3 (fr)
UA (1) UA19333A (fr)
YU (1) YU47122B (fr)
ZA (1) ZA888428B (fr)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258360B1 (en) * 1989-05-04 2001-07-10 Igen International, Inc. Prodrugs activated by targeted catalytic proteins
US5527782A (en) * 1990-03-13 1996-06-18 Acic (Canada) Inc. 5-halo-2,3'-O-cyclocytidines
TW254946B (fr) * 1992-12-18 1995-08-21 Hoffmann La Roche
AU671491B2 (en) * 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
US5476932A (en) * 1994-08-26 1995-12-19 Hoffmann-La Roche Inc. Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
IT1291983B1 (it) * 1997-05-23 1999-01-25 Pro Bio Sint Srl Prodcedimento per la preparazione di un derivato della desossiuridina
EP0882734B1 (fr) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag Dérivés de 5'-déoxy-cytidine
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20010051348A1 (en) * 2000-01-28 2001-12-13 Lee Chee Wee Novel ligands and methods for preparing same
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1490090A4 (fr) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs
US6774758B2 (en) * 2002-09-11 2004-08-10 Kalyan P. Gokhale Low harmonic rectifier circuit
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
AU2003233586A1 (en) * 2003-05-20 2005-01-21 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising capecitabine and a liposomal platinum complex
ES2310298T3 (es) * 2003-12-22 2009-01-01 F. Hoffmann-La Roche Ag Proceso para producir derivados de fluorocitidina.
KR20070007104A (ko) * 2004-02-18 2007-01-12 아스트라제네카 아베 화합물
EP1718624B1 (fr) * 2004-02-18 2009-03-25 AstraZeneca AB Derives de benzamide et leur utilisation en tant qu'activateurs de la glucokinase
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4－氧羰基胞嘧啶衍生物及制备方法与应用
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
KR101061850B1 (ko) 2004-09-08 2011-09-02 삼성전자주식회사 박막 트랜지스터 표시판 및 그 제조방법
GB0421294D0 (en) * 2004-09-24 2004-10-27 Angiogene Pharm Ltd Bioreductively-activated prodrugs
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
CA2581619A1 (fr) 2004-10-16 2006-04-20 Astrazeneca Ab Procede de fabrication de composes de phenoxy benzamide
SI1848414T1 (sl) 2005-02-03 2011-08-31 Gen Hospital Corp Postopek za zdravljenje raka, odpornega na gefitinib
NO322682B1 (no) * 2005-03-18 2006-11-27 Clavis Pharma Asa Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
WO2006103187A2 (fr) * 2005-04-01 2006-10-05 F. Hoffmann-La Roche Ag Methode d'administration de capecitabine
WO2006125958A1 (fr) * 2005-05-24 2006-11-30 Astrazeneca Ab Derives d’imidazol[4,5b]pyridine/pyrazine et purine substitues en 2-phenyl en tant que modulateurs de la glucokinase
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
NZ564608A (en) 2005-07-09 2009-09-25 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
JP2009500442A (ja) * 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
US20080234273A1 (en) * 2005-07-09 2008-09-25 Mckerrecher Darren Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
CN100569790C (zh) * 2005-07-15 2009-12-16 上海奥锐特国际贸易有限公司 合成n4-酰基-5＇-脱氧-5-氟胞苷衍生物的方法
EP1906977B1 (fr) * 2005-07-21 2012-02-22 Nuvo Research AG Solutions de chlorite stabilisees associees a des fluoropyrimidines pour traiter des cancers
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
RU2451524C2 (ru) 2005-11-04 2012-05-27 Вайет Противоопухолевые комбинации с ингибиторами mtor, герцептином и/или hki-272
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
CN100425617C (zh) * 2006-10-31 2008-10-15 浙江海正药业股份有限公司 一种含氟嘧啶类化合物烷氧羰酰化的方法
JP2010513445A (ja) 2006-12-21 2010-04-30 アストラゼネカ アクチボラグ Ｇｌｋアクチベーターとして有用な新規結晶性化合物
ITMI20070435A1 (it) 2007-03-05 2008-09-06 Innovate Biotechnology Srl 2',3'-di-o-acil-5-fluoronucleosidi
BRPI0810067A2 (pt) * 2007-04-20 2014-10-21 Reddys Lab Ltd Dr Processo para a preparação de capecitabina
EP2164856A1 (fr) * 2007-06-01 2010-03-24 Synthon B.V. Procédés se rapportant à la fabrication de la capécitabine
US8741858B2 (en) 2007-09-21 2014-06-03 Zhongxu Ren Oligomer-nucleoside phosphate conjugates
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
EP2225566A1 (fr) * 2008-01-03 2010-09-08 Plus Chemicals S.A. Procédé de préparation de capécitabine
NZ590009A (en) 2008-06-17 2012-08-31 Wyeth Llc Antineoplastic combinations containing hki-272 and vinorelbine
JP2011529955A (ja) 2008-08-04 2011-12-15 アストラゼネカ アクチボラグ 治療薬４１４
KR101434009B1 (ko) 2008-08-04 2014-08-25 와이어쓰 엘엘씨 4-아닐리노-3-사이아노퀴놀린과 카페시타빈의 항신생물성 조합물
EP2370414A4 (fr) * 2008-12-02 2012-11-14 Reddys Lab Ltd Dr Préparation de capécitabine
EP2393472B1 (fr) * 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Promédicaments amphiphiles
CN101787066B (zh) * 2009-01-23 2013-07-31 高峰 阿糖胞苷衍生物及其在抗癌抗肿瘤中的用途
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
CN103989681A (zh) 2009-04-06 2014-08-20 惠氏有限责任公司 用于乳腺癌的利用奈拉替尼的治疗方案
WO2010116176A1 (fr) * 2009-04-09 2010-10-14 Astrazeneca Ab Dérivé de pyrazolo [4, 5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
WO2010116177A1 (fr) 2009-04-09 2010-10-14 Astrazeneca Ab Dérivé de pyrazolo [4,5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité
CN101875680B (zh) * 2009-04-28 2012-07-25 上海信旗医药科技有限公司 一种核苷类化合物及其制备方法和应用
EP2456778A4 (fr) * 2009-07-23 2013-05-29 Scinopharm Taiwan Ltd Procédé de production de dérivés de la fluorocytidine
HUE027831T2 (en) 2010-03-12 2016-11-28 Genzyme Corp Combination therapy for breast cancer
CN108949772A (zh) 2012-04-02 2018-12-07 现代泰克斯公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
EP3520821A1 (fr) 2012-04-02 2019-08-07 Moderna Therapeutics, Inc. Polynucléotides modifiés pour la production d'agents biologiques et de protéines associées à une maladie humaine
JP6666147B2 (ja) 2012-09-26 2020-03-13 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 環状エーテルピラゾール−４−イル−ヘテロシクリル−カルボキサミド化合物と使用方法
WO2014074725A1 (fr) 2012-11-07 2014-05-15 Ohio State Innovation Foundation Analogues arylamides substitués de gemcitabine
WO2014152027A1 (fr) 2013-03-15 2014-09-25 Moderna Therapeutics, Inc. Procédés de fabrication pour la production de transcrits d'arn
EP2968382B1 (fr) * 2013-03-15 2018-03-07 Nucorion Pharmaceuticals, Inc. Analogues d'amide bicyclique de gemcitabine substitués et méthodes de traitement à l'aide de ceux-ci
WO2015034925A1 (fr) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Polynucléotides circulaires
CA2923029A1 (fr) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Polynucleotides chimeriques
CN103450301B (zh) * 2013-09-09 2015-09-09 南通大学 法尼基硫代水杨酸-核苷缀合物、其制备方法及其医药用途
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
RU2770081C2 (ru) * 2016-06-28 2022-04-14 Селликс Био Прайвет Лимитед Композиции и способы для лечения рака
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
CA3049435A1 (fr) 2017-01-09 2018-07-12 Scott Grindrod Inhibiteurs selectifs d'histone deacetylase pour le traitement d'une maladie humaine
WO2018200859A1 (fr) 2017-04-26 2018-11-01 Kalman Thomas I Dérivés de nucléoside multicibles
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
EP3737376B1 (fr) 2018-01-09 2024-04-17 Shuttle Pharmaceuticals, Inc. Inhibiteurs sélectifs d'histone déacétylase pour le traitement de maladies humaines
EP3752511A4 (fr) 2018-01-10 2021-12-29 Nucorion Pharmaceuticals, Inc. Composés de phosphore(n)amidatacétal et phosph(on)atalcétal
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
WO2019143860A1 (fr) * 2018-01-19 2019-07-25 Nucorion Pharmaceuticals, Inc. Composés de 5-fluorouracile
SG11202100411TA (en) * 2018-08-03 2021-02-25 Cellix Bio Private Ltd Compositions and methods for the treatment of cancer
CN109651467A (zh) * 2019-01-15 2019-04-19 齐鲁天和惠世制药有限公司 一种卡培他滨杂质及其制备方法
EP3999519A4 (fr) 2019-07-17 2023-08-16 Nucorion Pharmaceuticals, Inc. Composés désoxyribonucléotidiques cycliques
WO2021216427A1 (fr) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Composés de promédicaments nucléotidiques
US20230295257A1 (en) 2020-07-24 2023-09-21 Strand Therapeutics Inc. Lipid nanoparticle comprising modified nucleotides
US20240166707A1 (en) 2021-01-08 2024-05-23 Strand Therapeutics Inc. Expression constructs and uses thereof
JP2025516226A (ja) 2022-04-26 2025-05-27 ストランド セラピューティクス インコーポレイテッド ベネズエラウマ脳炎（ｖｅｅ）レプリコンを含む脂質ナノ粒子及びその使用
WO2025193628A2 (fr) 2024-03-09 2025-09-18 Aadigen, Llc Compositions de traitement du cancer à mutations de kras et leurs utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404144A (en) * 1965-12-23 1968-10-01 Research Corp 1-beta-d-arabinofuranosyl-5-fluorocytosine compounds
GB1379410A (en) * 1971-06-08 1975-01-02 Upjohn Co 1-beta-d-arabino-furanosyl-n4-alpha-aminoacylcytosines
JPS52153977A (en) * 1976-06-11 1977-12-21 Daikin Ind Ltd Synthesis of 5-fluorouracil and its derivatives
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
CH633810A5 (en) * 1978-01-01 1982-12-31 Hoffmann La Roche Novel nucleosides and process for their preparation
FR2528311B1 (fr) * 1982-06-14 1985-06-14 Synthelabo Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
JPS61112093A (ja) * 1984-11-05 1986-05-30 Wakunaga Seiyaku Kk ヌクレオチド誘導体

Also Published As

Publication number Publication date
EP0316704A3 (en) 1990-11-22
PT89009B (pt) 1993-02-26
IS1895B (is) 2003-10-20
MC1992A1 (fr) 1989-11-30
UA19333A (uk) 1997-12-25
CA1327358C (fr) 1994-03-01
NZ226923A (en) 1990-10-26
IE883430L (en) 1989-05-17
NL300045I2 (nl) 2002-01-02
IL88363A0 (en) 1989-06-30
FI885329A0 (fi) 1988-11-17
MX173347B (es) 1994-01-03
SU1736342A3 (ru) 1992-05-23
ZA888428B (en) 1989-06-28
FI885329L (fi) 1989-05-18
NO2001013I2 (no) 2006-05-01
ES2074429T3 (es) 1995-09-16
HU199866B (en) 1990-03-28
DE10199027I1 (de) 2001-08-02
YU209188A (en) 1990-08-31
DK640388D0 (da) 1988-11-16
DZ1270A1 (fr) 2004-09-13
LU90769I2 (fr) 2001-07-02
KR970000241B1 (ko) 1997-01-08
NO171167B (no) 1992-10-26
DE3854148D1 (de) 1995-08-17
CN1033183A (zh) 1989-05-31
ATE124951T1 (de) 1995-07-15
YU47122B (sh) 1994-12-28
NO885106D0 (no) 1988-11-16
MX13836A (es) 1993-10-01
JPH0678350B2 (ja) 1994-10-05
HUT48267A (en) 1989-05-29
FI89804B (fi) 1993-08-13
FI89804C (fi) 1993-11-25
EP0316704B1 (fr) 1995-07-12
LT2185B (lt) 1993-10-15
NO171167C (no) 1993-02-03
HK1003114A1 (en) 1998-10-09
CN1022688C (zh) 1993-11-10
PT89009A (pt) 1988-12-01
GR3017686T3 (en) 1996-01-31
AR247217A1 (es) 1994-11-30
US4966891A (en) 1990-10-30
PH25641A (en) 1991-08-21
EP0316704A2 (fr) 1989-05-24
JPH01153696A (ja) 1989-06-15
AU2516888A (en) 1989-05-25
DK170893B1 (da) 1996-03-04
KR890008162A (ko) 1989-07-10
DE10199027I2 (de) 2002-01-31
AU619220B2 (en) 1992-01-23
CS274486B2 (en) 1991-04-11
IS3412A7 (is) 1989-05-18
NL300045I1 (nl) 2001-08-01
NO885106L (no) 1989-05-18
CS747588A2 (en) 1990-09-12
DK640388A (da) 1989-05-18

Similar Documents

Publication Publication Date Title
LV5624A3 (lv) Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai
DK434088A (da) Epipodophyllotoxinglucosid-4'-phosphatderivater
DE3856154D1 (de) Adenosin-Derivate
DK54488A (da) Adenosin-5'-carboxamid-derivater
TR26815A (tr) Azolilmetil-sikropil türevleri
DK564088A (da) Nukleosidderivater
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188A (da) Cholecalciferolderivater
DK378088A (da) Alkenderivater
DK49688A (da) Propiolophenonderivater
DK71187D0 (da) Purinderivater
DK702688D0 (da) Epipodophyllotoxin-glucosid 4'-acylderivater
DK271088A (da) Tienopyridinderivater
FI893041A7 (fi) Substituoidut atsasykloheksyylijohdannaiset
DK695788A (da) Naphtalenderivater
FR2602233B1 (fr) Derives de l'isoquinoleine
DK733688A (da) Dioxazocinderivater
DK71488D0 (da) Dipenylethylen-derivater
FR2603282B1 (fr) Derives d'isoquinoleine
ATA87988A (de) Pflugnachlaeufer
ES2022963B3 (es) Arado
DK204089D0 (da) Plov
ATA78088A (de) Pflugnachlaeufer
DK313789A (da) Thiadiazinonderivater
KR890012275U (ko) 경운기용 배토기